97 results on '"Roberto Massimo Lemoli"'
Search Results
2. Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA
3. S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION
4. P381: FULL PEDIATRIC INDUCTION IN ADULTS AGED UP TO 55 YEARS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IS WELL TOLERATED AND RESULTS IN VERY HIGH CURE RATE
5. P530: CPX-351 INDUCTION IS ABLE TO INDUCE MRD NEGATIVE CR IN A SIGNIFICATIVE PROPORTION OF VERY HIGH RISK AML PATIENTS, REGARDLESS OF MUTATIONAL BURDEN, ALLOWING FOR BRIDGING TO TRANSPLANTATION
6. P553: PRELIMINARY RESULTS OF MRD ANALYSIS OF AML1718, A PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, IDARUBICIN AND CYTARABINE (V-FLAI) IN THE INDUCTION THERAPY OF NON LOW-RISK AML
7. PB1742: FEASIBILITY AND EFFICACY OF A PEG-ASPARAGINASE-BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
8. Harnessing Immune Response in Acute Myeloid Leukemia
9. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
10. Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis
11. Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
12. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function
13. Harnessing NK Cells for Cancer Treatment
14. Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden
15. Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
16. Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia
17. Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated with Expansion and Maturation of NK Cells
18. Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
19. Gimema ALL2418: Interim Analysis of a Phase Iia Study of Feasibility and Effectiveness of Inotuzumab Ozogamicin in Adult Patients with B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease before Any Hematopoietic Stem Cell Transplantation
20. Blastic Plasmacytoid Dendritic Cell Neoplasm Treated with Approved CD123-Targeted Therapy Tagraxofusp: The First European Real-World Evidence Prospective Registry of First-Line Adult Patients
21. Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
22. Prognostic Relevance of Minimal Residual Disease in Therapy Related and Secondary Acute Myeloid Leukemia Receiving CPX-351 or Fludarabine-Based Induction
23. Clonal Hematopoiesis: Exploiting Molecular Landscape of Multiple Myeloma Patients for Choosing the Most Appropriate Therapeutic Strategy
24. Fluorescence-guided laparoscopic lymph node biopsy in a lymphoma patient: a possible new clinical application of indocyanine green
25. The Multi-Kinases Inhibitor ARQ531 Enhanches Anti-MM Activity of Imids By Dual Deregulation of MAP- and Cyclin-Dependent Kinases Activities
26. Molecular and functional characterization of CD133
27. Move on air: Webinar for education in stem cells mobilization Report I
28. Autologous haematopoietic stem cell mobilization with plerixafor and G-CSF: impact of overweight and obesity
29. Haematopoietic stem cell mobilization with plerixafor in patients with non-haematological diseases
30. Pegfilgrastim for mobilization of stem cells in allogeneic donors
31. Dendritic cell differentiation from hematopoietic CD34+ progenitor cells
32. Kinetics variation of CD34+ and CD34+CD90+ in subjects following different mobilizing protocols
33. Dendritic cells: specialized antigen presenting cells
34. Opposite regulation of p27 in bone marrow and G-CSF mobilized peripheral blood CD34+ cells
35. Induction of a functional vitamin D receptor in all-trans-retinoic acid- induced monocytic differentiation of M2-type leukemic blast cells
36. Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells
37. Autologous haematopoietic stem cell mobilization with plerixafor and G-CSF: impact of apheresis volume. Data from the Plerixafor European Compassionate Use Study
38. Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML)
39. COMORBIDITY AND BODY MASS INDEX IN PATIENTS WITH POLYCYTHEMIA VERA: A PV-NET STUDY
40. A novel subset of CD34-leukemic stem cells in chronic myelogenous leukemia (CML) appear to be poorly responsive to imatinib treatment in vitro
41. Molecular profile of CD34(+) stem cells in essential thrombocythemia according to JAK2 expression
42. EXVIVO TREATMENT OF MYELOMA CELLS BY 4-HC, VP-16, LAK CELLS AND ANTIBODIES
43. POSACONAZOLE AS PRIMARY PROPHYLAXIS REDUCES INVASIVE FUNGAL INFECTIONS IN AML PATIENTS: A SINGLE CENTRE MATCHED PAIRED ANALYSIS
44. HIGH CURE RATE OF YOUNGER AML PATIENTS WITH FLUDARABINE, CYTARABINE AND IDARUBICINE INDUCTION AND RISK ORIENTED CONSOLIDATION: TEN- YEARS REAL LIFE EXPERIENCE
45. A BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM-LIKE PHENOTYPE IDENTIFIES A SUBGROUP OF NPM1-MUTATED AML PATIENTS WITH WORSE PROGNOSIS
46. Allogeneic peripheral blood stem cell transplantation: Increased incidence of both acute and chronic GVHD
47. POSITIVE SELECTION AND TRANSPLANTATION OF CIRCULATING CD34+ CELLS IN MULTIPLE-MYELOMA (MM) PATIENTS
48. PROLIFERATION OF HUMAN HEMATOPOIETIC PROGENITORS IN LONG-TERM BONE-MARROW CULTURES IN GAS-PERMEABLE PLASTIC BAGS IS ENHANCED BY COLONY-STIMULATING FACTORS
49. Pilot study of selection and transplantation of autologous highly purified CD133(+) stem cells in chronic lymphocytic leukemia patients with advanced disease
50. PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF CD4+CD25+REGULATORY T CELLS IN CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.